BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 29789480)

  • 1. Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer.
    Zhou L; Zhao B; Zhang L; Wang S; Dong D; Lv H; Shang P
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29789480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron as a Central Player and Promising Target in Cancer Progression.
    Jung M; Mertens C; Tomat E; Brüne B
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel chelators for cancer treatment: where are we now?
    Merlot AM; Kalinowski DS; Richardson DR
    Antioxid Redox Signal; 2013 Mar; 18(8):973-1006. PubMed ID: 22424293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular iron homeostasis and therapeutic implications of iron chelators in cancer.
    Raza M; Chakraborty S; Choudhury M; Ghosh PC; Nag A
    Curr Pharm Biotechnol; 2014; 15(12):1125-40. PubMed ID: 25496094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron: An Essential Element of Cancer Metabolism.
    Hsu MY; Mina E; Roetto A; Porporato PE
    Cells; 2020 Dec; 9(12):. PubMed ID: 33287315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A promising new approach to cancer therapy: Targeting iron metabolism in cancer stem cells.
    El Hout M; Dos Santos L; Hamaï A; Mehrpour M
    Semin Cancer Biol; 2018 Dec; 53():125-138. PubMed ID: 30071257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine targets iron metabolism for cancer therapy.
    Lin L; Chen H; Zhao R; Zhu M; Nie G
    Cancer Sci; 2022 Mar; 113(3):828-837. PubMed ID: 34962017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron and cancer: more ore to be mined.
    Torti SV; Torti FM
    Nat Rev Cancer; 2013 May; 13(5):342-55. PubMed ID: 23594855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Promising New Anti-Cancer Strategy: Iron Chelators Targeting CSCs.
    Chen Y; Ohara T; Xing B; Qi J; Noma K; Matsukawa A
    Acta Med Okayama; 2020 Feb; 74(1):1-6. PubMed ID: 32099242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of iron metabolism in cancer stem cells.
    Recalcati S; Gammella E; Cairo G
    Free Radic Biol Med; 2019 Mar; 133():216-220. PubMed ID: 30040994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Roles of NRF2 in Modulating Cellular Iron Homeostasis.
    Kerins MJ; Ooi A
    Antioxid Redox Signal; 2018 Dec; 29(17):1756-1773. PubMed ID: 28793787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron metabolism and drug resistance in cancer.
    Kazan HH; Urfali-Mamatoglu C; Gunduz U
    Biometals; 2017 Oct; 30(5):629-641. PubMed ID: 28766192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipocalin-2 and iron trafficking in the tumor microenvironment.
    Jung M; Mertens C; Bauer R; Rehwald C; Brüne B
    Pharmacol Res; 2017 Jun; 120():146-156. PubMed ID: 28342790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron and leukemia: new insights for future treatments.
    Wang F; Lv H; Zhao B; Zhou L; Wang S; Luo J; Liu J; Shang P
    J Exp Clin Cancer Res; 2019 Sep; 38(1):406. PubMed ID: 31519186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of iron in cancer.
    Salnikow K
    Semin Cancer Biol; 2021 Nov; 76():189-194. PubMed ID: 33901632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting cancer by binding iron: Dissecting cellular signaling pathways.
    Lui GY; Kovacevic Z; Richardson V; Merlot AM; Kalinowski DS; Richardson DR
    Oncotarget; 2015 Aug; 6(22):18748-79. PubMed ID: 26125440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron Metabolism in Cancer Progression.
    Forciniti S; Greco L; Grizzi F; Malesci A; Laghi L
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32214052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron metabolism: an emerging therapeutic target underlying the anti-cancer effect of quercetin.
    Yin M; Liu Y; Chen Y
    Free Radic Res; 2021 Mar; 55(3):296-303. PubMed ID: 33818251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular reduction/activation of a disulfide switch in thiosemicarbazone iron chelators.
    Akam EA; Chang TM; Astashkin AV; Tomat E
    Metallomics; 2014 Oct; 6(10):1905-12. PubMed ID: 25100578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of lipid metabolism alterations in Cancer stem cells.
    Yi M; Li J; Chen S; Cai J; Ban Y; Peng Q; Zhou Y; Zeng Z; Peng S; Li X; Xiong W; Li G; Xiang B
    J Exp Clin Cancer Res; 2018 Jun; 37(1):118. PubMed ID: 29907133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.